Mesothelioma v/s adenocarcinoma of lung do serum markers help?
作者信息
Gupta Neeraj
机构信息
Assistant Professor, Deptt of Respiratory Diseases & Tuberculosis JLN Medical College, Ajmer (Raj.) 305001.
出版信息
Lung India. 2008 Oct;25(4):172. doi: 10.4103/0970-2113.45287.
Abstract
摘要
相似文献
1
Mesothelioma v/s adenocarcinoma of lung do serum markers help?间皮瘤与肺腺癌：血清标志物有帮助吗？
Lung India. 2008 Oct;25(4):172. doi: 10.4103/0970-2113.45287.
2
MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.MUC4 免疫组织化学在鉴别肺上皮样间皮瘤与肺腺癌和肺鳞癌方面是有用的。
Sci Rep. 2018 Jan 9;8(1):134. doi: 10.1038/s41598-017-18545-x.
3
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.区分恶性胸膜间皮瘤与肺腺癌的多标记免疫组化表型
Hum Pathol. 1993 Apr;24(4):347-54. doi: 10.1016/0046-8177(93)90080-z.
4
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.葡萄糖转运蛋白-1（Glut-1）和Koc标志物在反应性间皮增生、恶性间皮瘤和肺腺癌鉴别诊断中的价值。
Turk Patoloji Derg. 2013;29(2):94-100. doi: 10.5146/tjpath.2013.01158.
5
Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.小窝蛋白-1是一种用于区分上皮样间皮瘤和肺腺癌的新型免疫组化标志物。
Histopathology. 2009 Jul;55(1):10-9. doi: 10.1111/j.1365-2559.2009.03322.x.
6
[Expression of mesothelin as a potential diagnostic marker in mesothelioma].间皮素作为间皮瘤潜在诊断标志物的表达
Nihon Kokyuki Gakkai Zasshi. 2008 Jan;46(1):3-9.
7
Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.恶性间皮瘤、肺腺癌和非肿瘤性肺组织中不同的DNA甲基化谱。
Lung Cancer. 2005 Feb;47(2):193-204. doi: 10.1016/j.lungcan.2004.08.003.
8
CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.CD90 是一种免疫组织化学诊断标志物，可用于区分恶性胸膜间皮瘤和肺癌。
Am J Clin Pathol. 2013 Oct;140(4):544-9. doi: 10.1309/AJCPM2Z4NGIIPBGE.
9
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.黏蛋白 21 是一种新型的上皮型间皮瘤阴性免疫组化标志物，可用于其与肺腺癌的鉴别诊断。
Histopathology. 2019 Mar;74(4):545-554. doi: 10.1111/his.13775. Epub 2019 Jan 15.
10
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.微小RNA-130A作为在胸腔积液细胞学中区分恶性间皮瘤与肺腺癌的诊断标志物。
Cancer Cytopathol. 2017 Aug;125(8):635-643. doi: 10.1002/cncy.21869. Epub 2017 Apr 27.
本文引用的文献
1
25-year old male with pleural thickening.25岁男性，伴有胸膜增厚。
Lung India. 2008 Apr;25(2):82-4. doi: 10.4103/0970-2113.44126.
2
Management of malignant pleural mesothelioma.恶性胸膜间皮瘤的管理
Clin Chest Med. 2006 Jun;27(2):335-54. doi: 10.1016/j.ccm.2006.01.004.
3
Mesothelin-family proteins and diagnosis of mesothelioma.间皮素家族蛋白与间皮瘤的诊断
Lancet. 2003 Nov 15;362(9396):1612-6. doi: 10.1016/S0140-6736(03)14794-0.
4
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.在卵巢癌患者的血清中可检测到间皮素/巨核细胞增强因子家族的可溶性成员。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11531-6. doi: 10.1073/pnas.96.20.11531.
5
Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
Eur J Cardiothorac Surg. 1991;5(9):466-72; discussion 473. doi: 10.1016/1010-7940(91)90142-7.
Zotero 插件